Member Info for leer75

Im with Llyods so don't have this issue, so can't comment. I sold my UK shares and bought NASDAQ a few months back in preparation.

Yes they have created a selling environment but unintentionally no doubt. The CEO is not stupid though, he knows that organizational matters have severely reduced investors perception on TILS but he is a decent man, given that his partner passed away from breast cancer and he has openly stated his desire to make progress in that field. The money will be secondary and hopefully he will recover his pride by progressing their trials successfully. As long as the current board remains intact it will recover but timing is unknown

Futhermore Accustem would have been part of the sell when the initial raise came earlier this year, there has been zero announcements on Accustem and as far as we are aware it has no board or employees, didn't Dr Kunwar Shailubhai say in an interview he has no dealings with it as it's a seperate entity? Although he is on the website as a director. I strongly believe the last 6 months has left Gabriele Cerrone in a daze how the market has correctly rerated due to terrible communications. They are spending money on a trial that will most likely be superceded by a big pharmas product. Covid has allowed them to raise significant funds on the back of it but has allowed Cerrone to lose some focus.

I hope you are right but there is lots of pharma research in publication that shows negative results have a much longer effect on market caps then positive news. One hypothesis is that negative announcements leave an imprint on investor perceptions of the company or confidence in the ability of senior management to conduct well-run clinical trials—that is, negative events may have a ‘reputational’ effect. I believe this is a hole TILS have fallen into with the car crash handling of Accustem and ending of UK listing. It gives an impression that the directors do not know what they are doing and if they can mess this up, why would you trust them with your money to run more trials. There are plenty of other pharma without this baggage, we will get a raise on NASDAQ but don't expect anything over £1.00 soon. Invester confidence in TILS is currently rock bottom, it will go up but slowly this time.

TILS has been a very disappointing share over the last 12 months and any director that sees their personal value of shares drop this much will be hurting. He will know that financial options for funding will be reduced and agreements less favorable for a falling stock. Hopefully some of their goals hit the right spot in the future before the next fund raise in 18months. Otherwise TILS will be in trouble, stage 3 trials are very expensive and currently TILS will have very few institutions willing to cough up £50 million plus

Low volume equals large spread…..

1st of October too?

Sold out as Looks like it’s going to 2p, could be worth getting back in before end of month at this rate

Utter nonesense I'm with Lloyds and they would simply complete a negoitated trade, MMS do hold some shares you are just not guaranteed the price

Boris is on the podium on Tuesday and after loooking at the figures, it's clear PCR tests will stay in place for Red countries and I wouldnt be surprised if they remained for amber countires till early next year. MHC needs to pivot into whatever is coming next and bring forward to new tests. Hospital admissions are still rising and it is impossible to think they will fall between now and next spring. This is with 80% of the country double jabbed, numbers are not going down just creeping up slowly. Given the horlicks made at the beginning with open borders, it is highly unlikely the gravy train will stop overnight. The numbers do not back it up. Sajid Javid, has a point about the cost of PCRs for familiies and this should be addressed with reduced margins and LFT for green countries. Keeping the country safe should come before anyones wish for a cheaper holiday. Ryan air have already said the prices are going to rocket next year so the government can't do anything about that. Plus if numbers starting rising world wide over autumn and winter the government will insist on PCR tests as the satndard. The biggest economies have controlled their borders much more firmly than the UK to our cost, Javid wants to get the working classes on side but couldnt give any indication of when what or how yesterday, depsite the Mail piece. Watch this space as Tuesday will be vital, I feel Boris will mirror what Javid said as he is the original loose cannon but will be loose on detail. IMO it's folly to get rid of PCRs given what happened last Xmas.....

NASDAQ
Looks like the usual short gang, trying to suppress the price again. Lets see where it ends at 9pm tonight.....

6.3million in a day, must be an ii banking some profits. Tomorrow will be key

Even adding both stocks together is a massive loss for institutions. If this isn’t resolved with some upward movement in the next 12-18mths, Tils will struggle to raise a penny in the future. The BOD are under real pressure to perform or this will be just another pump and raise stock

Sharedealer….
This was never about money, that was clear the RTO details royally rogered everyone! I was quite happy to lose my possible £200, at the end of the day where can you tell board of directors you have been shambolic and this is my way of telling you straight! The cost of a trip to an AGM would have been more!! But this is without doubt as satisfying a conclusion we could have achieved. These fools will now been known for this crock for much longer than I will remember the money I lost. Who is going want a director that stabbed their shareholders in the front not back then wanted a sweetener deal for themselves! Steak and bubbly for me tonight!

Either way share holders have stood up to having their trousers pulled down whilst inept directors cream the results. Who knows if they come back with something else, however given that they have just raised 10 million at significant cost as fund raises are not a free service, they clearly will have to do something or the new business will be lumbered with some significant debts! Well done people, we will not be their urinal tonight or tomorrow. Sleep well

This is without doubt shambolic treatment by the current board, after months of positive spin about value and prospective rto candidates we are presented with this and treated with utter contempt. It’s like the ex threatening to take away your kids if you don’t agree to massive payments you can’t afford. Rock and hard place…

Same old waffle with no mention of value for previous shareholders, what a difference a RNS makes…… not

It’s now pretty obvious this RTO was all smoke and mirrors. With the greatest respect to BiVictriX, it’s purpose may be very noble but as pharma companies go it’s near the bottom of a growing pile. The ceo may be an amazing scientist but their staff profiles on LinkedIn highlight professionals who have literally just started their working life. Stood next to other AIM pharma boards you would be hard pressed to invest in here. People invest in people and they have to make you believe in their goal. If this was the best rto option the others must have been truly appalling. There’s a reason why the English chief medical officer is a person with decades of medical experience. I truly hope BiVictriX is a success but I doubt it. Will keep it on my watch list wait for the inevitable

novicehunter thanks for the correction, however you spell it, you cannot polish a turd! In fact the tax right off would be worth more! So it’s a vote no from me

RosieNas
The only thing worrying here, is that as RTOs go this is as damp any squid can possibly ever get......